• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过融合活性病毒体将蛋白质抗原递送至免疫系统:与脂质体和免疫刺激复合物的比较。

Delivery of protein antigens to the immune system by fusion-active virosomes: a comparison with liposomes and ISCOMs.

作者信息

Bungener Laura, Huckriede Anke, Wilschut Jan, Daemen Toos

机构信息

Department of Medical Microbiology, University of Groningen, The Netherlands.

出版信息

Biosci Rep. 2002 Apr;22(2):323-38. doi: 10.1023/a:1020198908574.

DOI:10.1023/a:1020198908574
PMID:12428908
Abstract

The induction of effective cellular and humoral immune responses against protein antigens is of major importance in vaccination strategies against infectious diseases and cancer. Immunization with protein alone in general does not result in efficient induction of cytotoxic T lymphocyte (CTL) and antibody responses. Numerous other immunization strategies have been explored. In this review we will discuss a number of lipid-based antigen delivery systems suitable for the induction of CTL responses. These systems comprise reconstituted virus envelopes (virosomes), liposomes, and immune-stimulating complexes (ISCOMs). We will concentrate on delivery of the protein antigen ovalbumin (OVA) since extensive studies with this antigen have been performed for all of the systems discussed, allowing direct comparison of antigen delivery efficiency. Stimulation of CTL activity requires processing of the antigen in the cytosol of antigen-presenting cells (APCs) and presentation of antigenic peptides on surface major histocompatibility class I complexes (MHC class I). In vitro, the ability of antigen delivery systems to induce MHC class I presentation indeed correlates with their capacity to deliver antigen to the cytosol of cells. This capacity appears to be less important for the induction of cytotoxic T lymphocytes in vivo. Instead, other properties of the antigen delivery system like activation of APCs and induction of T helper cells play a more prominent role. Fusion-active virosomes appear to be a very potent system for induction of CTL activity, most likely since virosomes combine efficient delivery of antigen with general stimulation of the immune system.

摘要

诱导针对蛋白质抗原的有效细胞免疫和体液免疫反应在针对传染病和癌症的疫苗接种策略中至关重要。一般来说,单独用蛋白质进行免疫接种不会有效诱导细胞毒性T淋巴细胞(CTL)和抗体反应。人们已经探索了许多其他免疫接种策略。在这篇综述中,我们将讨论一些适合诱导CTL反应的基于脂质的抗原递送系统。这些系统包括重组病毒包膜(病毒体)、脂质体和免疫刺激复合物(ISCOM)。我们将重点讨论蛋白质抗原卵清蛋白(OVA)的递送,因为针对所有所讨论的系统都对该抗原进行了广泛研究,从而能够直接比较抗原递送效率。刺激CTL活性需要抗原呈递细胞(APC)的胞质溶胶中对抗原进行加工,并在表面主要组织相容性复合体I类(MHC I类)上呈递抗原肽。在体外,抗原递送系统诱导MHC I类呈递的能力确实与其将抗原递送至细胞胞质溶胶的能力相关。这种能力在体内诱导细胞毒性T淋巴细胞方面似乎不太重要。相反,抗原递送系统的其他特性,如APC的激活和辅助性T细胞的诱导,发挥着更突出的作用。具有融合活性的病毒体似乎是诱导CTL活性的非常有效的系统,这很可能是因为病毒体将抗原的有效递送与免疫系统的一般刺激结合在一起。

相似文献

1
Delivery of protein antigens to the immune system by fusion-active virosomes: a comparison with liposomes and ISCOMs.通过融合活性病毒体将蛋白质抗原递送至免疫系统:与脂质体和免疫刺激复合物的比较。
Biosci Rep. 2002 Apr;22(2):323-38. doi: 10.1023/a:1020198908574.
2
Virosomes for antigen and DNA delivery.用于抗原和DNA递送的病毒体。
Adv Drug Deliv Rev. 2005 Jan 10;57(3):451-63. doi: 10.1016/j.addr.2004.09.005.
3
Virosome-mediated delivery of protein antigens to dendritic cells.病毒体介导的蛋白质抗原向树突状细胞的递送。
Vaccine. 2002 May 22;20(17-18):2287-95. doi: 10.1016/s0264-410x(02)00103-2.
4
Virosome-mediated delivery of protein antigens in vivo: efficient induction of class I MHC-restricted cytotoxic T lymphocyte activity.病毒体介导的蛋白质抗原体内递送:I类主要组织相容性复合体限制的细胞毒性T淋巴细胞活性的有效诱导
Vaccine. 2005 Jan 26;23(10):1232-41. doi: 10.1016/j.vaccine.2004.09.002.
5
Induction of cytotoxic T lymphocyte activity by fusion-active peptide-containing virosomes.含融合活性肽的病毒体诱导细胞毒性T淋巴细胞活性
Vaccine. 2000 Jan 31;18(14):1327-33. doi: 10.1016/s0264-410x(99)00404-1.
6
Liposomal delivery of CTL epitopes to dendritic cells.细胞毒性T淋巴细胞(CTL)表位的脂质体递送至树突状细胞
Biosci Rep. 2002 Apr;22(2):339-53. doi: 10.1023/a:1020151025412.
7
Listeriolysin O-liposome-mediated cytosolic delivery of macromolecule antigen in vivo: enhancement of antigen-specific cytotoxic T lymphocyte frequency, activity, and tumor protection.李斯特菌溶血素O脂质体介导的体内大分子抗原胞质递送:增强抗原特异性细胞毒性T淋巴细胞频率、活性及肿瘤保护作用
Biochim Biophys Acta. 2002 Jun 13;1563(1-2):7-17. doi: 10.1016/s0005-2736(02)00368-1.
8
Fusogenic liposomes efficiently deliver exogenous antigen through the cytoplasm into the MHC class I processing pathway.融合脂质体可有效地将外源性抗原通过细胞质递送至MHC I类加工途径。
Eur J Immunol. 2000 Jun;30(6):1740-7. doi: 10.1002/1521-4141(200006)30:6<1740::AID-IMMU1740>3.0.CO;2-U.
9
Cytosolic Delivery of Liposomal Vaccines by Means of the Concomitant Photosensitization of Phagosomes.通过吞噬体的伴随光敏化实现脂质体疫苗的胞质递送。
Mol Pharm. 2016 Feb 1;13(2):320-9. doi: 10.1021/acs.molpharmaceut.5b00394. Epub 2016 Jan 6.
10
The role of macrophages in the induction and regulation of immunity elicited by exogenous antigens.
Eur J Immunol. 1998 Feb;28(2):479-87. doi: 10.1002/(SICI)1521-4141(199802)28:02<479::AID-IMMU479>3.0.CO;2-R.

引用本文的文献

1
Cell penetrating peptide: A potent delivery system in vaccine development.细胞穿透肽:疫苗研发中的一种有效递送系统。
Front Pharmacol. 2022 Nov 8;13:1072685. doi: 10.3389/fphar.2022.1072685. eCollection 2022.
2
Equine Influenza Virus and Vaccines.马流感病毒与疫苗。
Viruses. 2021 Aug 20;13(8):1657. doi: 10.3390/v13081657.
3
Cationic Nanostructures for Vaccines Design.用于疫苗设计的阳离子纳米结构
Biomimetics (Basel). 2020 Jul 7;5(3):32. doi: 10.3390/biomimetics5030032.
4
Pulmonary Delivery of Virosome-Bound Antigen Enhances Antigen-Specific CD4 T Cell Proliferation Compared to Liposome-Bound or Soluble Antigen.与脂质体结合抗原或可溶性抗原相比,病毒体结合抗原的肺部给药可增强抗原特异性CD4 T细胞增殖。
Front Immunol. 2017 Apr 7;8:359. doi: 10.3389/fimmu.2017.00359. eCollection 2017.
5
A Systematic Review of Recent Advances in Equine Influenza Vaccination.马流感疫苗接种最新进展的系统评价
Vaccines (Basel). 2014 Nov 14;2(4):797-831. doi: 10.3390/vaccines2040797.
6
Novel antigen delivery systems.新型抗原递送系统。
World J Virol. 2015 Aug 12;4(3):156-68. doi: 10.5501/wjv.v4.i3.156.
7
Advanced antigen delivery of murine survivin: chimeric virus-like particles in cancer vaccine research.小鼠生存素的先进抗原递送:癌症疫苗研究中的嵌合病毒样颗粒
Int J Biomed Sci. 2007 Sep;3(3):199-205.
8
Strategies for intranasal delivery of vaccines.鼻腔内递呈疫苗的策略。
Drug Deliv Transl Res. 2013 Feb;3(1):100-9. doi: 10.1007/s13346-012-0085-z. Epub 2012 Jul 12.
9
Lipoidal soft hybrid biocarriers of supramolecular construction for drug delivery.用于药物递送的超分子结构脂质软杂化生物载体
ISRN Pharm. 2012;2012:474830. doi: 10.5402/2012/474830. Epub 2012 Jul 19.
10
Conference report--adjuvants and delivery: improving on vaccine immunogenicity highlights from the viral vaccine meeting; October 25-28, 2003; Barcelona, Spain.会议报告——佐剂与递送:提升疫苗免疫原性,2003年10月25日至28日于西班牙巴塞罗那召开的病毒疫苗会议亮点
MedGenMed. 2004 Jan 26;6(1):46.